Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Dermatology Drug Market 2018, Forecast to 2023

Publisher Name :
Date: 14-Jun-2018
No. of pages: 136

Dermatology Drug is used in the management and treatment of diseases related to skin. Acne, psoriasis, and dermatitis are some common skin diseases.

Scope of the Report:

This report focuses on the Dermatology Drug in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

The classification of Dermatology Drug includes External Use, Oral and Injection, and the revenue proportion of External Use in 2015 is about 73.74%.

Dermatology Drug is widely used for Psoriasis, Skin Infections, Acne, Dermatitis and other skin diseases. Amongst these different types of skin diseases, Psoriasis was the largest revenue generating segment in 2015, and the revenue market share is about 48.04%.

The worldwide market for Dermatology Drug is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.

Market Segment by Manufacturers, this report covers

- AbbVie

- Johnson & Johnson

- Bayer

- Galderma

- Bristol-Myers Squibb

- Novartis

- Pfizer

- Merz Pharma

- Valeant

- LEO Pharma

- GlaxoSmithKline

Market Segment by Regions, regional analysis covers

- North America (United States, Canada and Mexico)

- Europe (Germany, France, UK, Russia and Italy)

- Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

- South America (Brazil, Argentina, Colombia etc.)

- Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

- External Use

- Oral

- Injection

Market Segment by Applications, can be divided into

- Psoriasis

- Skin Infections

- Acne

- Dermatitis

- Other

There are 15 Chapters to deeply display the global Dermatology Drug market.

Chapter 1, to describe Dermatology Drug Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Dermatology Drug, with sales, revenue, and price of Dermatology Drug, in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the global market by regions, with sales, revenue and market share of Dermatology Drug, for each region, from 2013 to 2018;

Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;

Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;

Chapter 12, Dermatology Drug market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;

Chapter 13, 14 and 15, to describe Dermatology Drug sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source

Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Dermatology Drug Market 2018, Forecast to 2023

Table of Contents

1 Market Overview
1.1 Dermatology Drug Introduction
1.2 Market Analysis by Type
1.2.1 External Use
1.2.2 Oral
1.2.3 Injection
1.3 Market Analysis by Applications
1.3.1 Psoriasis
1.3.2 Skin Infections
1.3.3 Acne
1.3.4 Dermatitis
1.3.5 Other
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 AbbVie
2.1.1 Business Overview
2.1.1.1 AbbVie Description
2.1.1.2 AbbVie Headquarter, Main Business and Finance Overview
2.1.2 AbbVie Dermatology Drug Product Introduction
2.1.2.1 Dermatology Drug Production Bases, Sales Regions and Major Competitors
2.1.2.2 Dermatology Drug Product Information
2.1.3 AbbVie Dermatology Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.1.3.1 AbbVie Dermatology Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.1.3.2 Global AbbVie Dermatology Drug Market Share in 2017
2.2 Johnson & Johnson
2.2.1 Business Overview
2.2.1.1 Johnson & Johnson Description
2.2.1.2 Johnson & Johnson Headquarter, Main Business and Finance Overview
2.2.2 Johnson & Johnson Dermatology Drug Product Introduction
2.2.2.1 Dermatology Drug Production Bases, Sales Regions and Major Competitors
2.2.2.2 Dermatology Drug Product Information
2.2.3 Johnson & Johnson Dermatology Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2.3.1 Johnson & Johnson Dermatology Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2.3.2 Global Johnson & Johnson Dermatology Drug Market Share in 2017
2.3 Bayer
2.3.1 Business Overview
2.3.1.1 Bayer Description
2.3.1.2 Bayer Headquarter, Main Business and Finance Overview
2.3.2 Bayer Dermatology Drug Product Introduction
2.3.2.1 Dermatology Drug Production Bases, Sales Regions and Major Competitors
2.3.2.2 Dermatology Drug Product Information
2.3.3 Bayer Dermatology Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3.3.1 Bayer Dermatology Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3.3.2 Global Bayer Dermatology Drug Market Share in 2017
2.4 Galderma
2.4.1 Business Overview
2.4.1.1 Galderma Description
2.4.1.2 Galderma Headquarter, Main Business and Finance Overview
2.4.2 Galderma Dermatology Drug Product Introduction
2.4.2.1 Dermatology Drug Production Bases, Sales Regions and Major Competitors
2.4.2.2 Dermatology Drug Product Information
2.4.3 Galderma Dermatology Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4.3.1 Galderma Dermatology Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4.3.2 Global Galderma Dermatology Drug Market Share in 2017
2.5 Bristol-Myers Squibb
2.5.1 Business Overview
2.5.1.1 Bristol-Myers Squibb Description
2.5.1.2 Bristol-Myers Squibb Headquarter, Main Business and Finance Overview
2.5.2 Bristol-Myers Squibb Dermatology Drug Product Introduction
2.5.2.1 Dermatology Drug Production Bases, Sales Regions and Major Competitors
2.5.2.2 Dermatology Drug Product Information
2.5.3 Bristol-Myers Squibb Dermatology Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5.3.1 Bristol-Myers Squibb Dermatology Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5.3.2 Global Bristol-Myers Squibb Dermatology Drug Market Share in 2017
2.6 Novartis
2.6.1 Business Overview
2.6.1.1 Novartis Description
2.6.1.2 Novartis Headquarter, Main Business and Finance Overview
2.6.2 Novartis Dermatology Drug Product Introduction
2.6.2.1 Dermatology Drug Production Bases, Sales Regions and Major Competitors
2.6.2.2 Dermatology Drug Product Information
2.6.3 Novartis Dermatology Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6.3.1 Novartis Dermatology Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6.3.2 Global Novartis Dermatology Drug Market Share in 2017
2.7 Pfizer
2.7.1 Business Overview
2.7.1.1 Pfizer Description
2.7.1.2 Pfizer Headquarter, Main Business and Finance Overview
2.7.2 Pfizer Dermatology Drug Product Introduction
2.7.2.1 Dermatology Drug Production Bases, Sales Regions and Major Competitors
2.7.2.2 Dermatology Drug Product Information
2.7.3 Pfizer Dermatology Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7.3.1 Pfizer Dermatology Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7.3.2 Global Pfizer Dermatology Drug Market Share in 2017
2.8 Merz Pharma
2.8.1 Business Overview
2.8.1.1 Merz Pharma Description
2.8.1.2 Merz Pharma Headquarter, Main Business and Finance Overview
2.8.2 Merz Pharma Dermatology Drug Product Introduction
2.8.2.1 Dermatology Drug Production Bases, Sales Regions and Major Competitors
2.8.2.2 Dermatology Drug Product Information
2.8.3 Merz Pharma Dermatology Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8.3.1 Merz Pharma Dermatology Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8.3.2 Global Merz Pharma Dermatology Drug Market Share in 2017
2.9 Valeant
2.9.1 Business Overview
2.9.1.1 Valeant Description
2.9.1.2 Valeant Headquarter, Main Business and Finance Overview
2.9.2 Valeant Dermatology Drug Product Introduction
2.9.2.1 Dermatology Drug Production Bases, Sales Regions and Major Competitors
2.9.2.2 Dermatology Drug Product Information
2.9.3 Valeant Dermatology Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9.3.1 Valeant Dermatology Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9.3.2 Global Valeant Dermatology Drug Market Share in 2017
2.10 LEO Pharma
2.10.1 Business Overview
2.10.1.1 LEO Pharma Description
2.10.1.2 LEO Pharma Headquarter, Main Business and Finance Overview
2.10.2 LEO Pharma Dermatology Drug Product Introduction
2.10.2.1 Dermatology Drug Production Bases, Sales Regions and Major Competitors
2.10.2.2 Dermatology Drug Product Information
2.10.3 LEO Pharma Dermatology Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10.3.1 LEO Pharma Dermatology Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10.3.2 Global LEO Pharma Dermatology Drug Market Share in 2017
2.11 GlaxoSmithKline
2.11.1 Business Overview
2.11.2 GlaxoSmithKline Dermatology Drug Product Introduction
2.11.3 GlaxoSmithKline Dermatology Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Dermatology Drug Market Competition, by Manufacturer
3.1 Global Dermatology Drug Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Dermatology Drug Revenue and Market Share by Manufacturer (2016-2017)
3.3 Global Dermatology Drug Price by Manufacturer (2016-2017)
3.4 Market Concentration Rate
3.4.1 Top 3 Dermatology Drug Manufacturer Market Share in 2017
3.4.2 Top 5 Dermatology Drug Manufacturer Market Share in 2017
3.5 Market Competition Trend
4 Global Dermatology Drug Market Analysis by Regions
4.1 Global Dermatology Drug Sales, Revenue and Market Share by Regions
4.1.1 Global Dermatology Drug Sales by Regions (2013-2018)
4.1.2 Global Dermatology Drug Revenue by Regions (2013-2018)
4.2 North America Dermatology Drug Sales, Revenue and Growth Rate (2013-2018)
4.3 Europe Dermatology Drug Sales, Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Dermatology Drug Sales, Revenue and Growth Rate (2013-2018)
4.5 South America Dermatology Drug Sales, Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Dermatology Drug Sales, Revenue and Growth Rate (2013-2018)
5 North America Dermatology Drug by Countries, Type, Application and Manufacturers
5.1 North America Dermatology Drug Sales, Revenue and Market Share by Countries
5.1.1 North America Dermatology Drug Sales by Countries (2013-2018)
5.1.2 North America Dermatology Drug Revenue by Countries (2013-2018)
5.1.3 United States Dermatology Drug Sales and Growth Rate (2013-2018)
5.1.4 Canada Dermatology Drug Sales and Growth Rate (2013-2018)
5.1.5 Mexico Dermatology Drug Sales and Growth Rate (2013-2018)
5.2 North America Dermatology Drug Sales and Revenue (Value) by Manufacturers (2016-2017)
5.2.1 North America Dermatology Drug Sales by Manufacturers (2016-2017)
5.2.2 North America Dermatology Drug Revenue by Manufacturers (2016-2017)
5.3 North America Dermatology Drug Sales, Revenue and Market Share by Type (2013-2018)
5.3.1 North America Dermatology Drug Sales and Sales Share by Type (2013-2018)
5.3.2 North America Dermatology Drug Revenue and Revenue Share by Type (2013-2018)
5.4 North America Dermatology Drug Sales, Revenue and Market Share by Application (2013-2018)
5.4.1 North America Dermatology Drug Sales and Sales Share by Application (2013-2018)
5.4.2 North America Dermatology Drug Revenue and Revenue Share by Application (2013-2018)
6 Europe Dermatology Drug by Countries, Type, Application and Manufacturers
6.1 Europe Dermatology Drug Sales, Revenue and Market Share by Countries
6.1.1 Europe Dermatology Drug Sales by Countries (2013-2018)
6.1.2 Europe Dermatology Drug Revenue by Countries (2013-2018)
6.1.3 Germany Dermatology Drug Sales and Growth Rate (2013-2018)
6.1.4 UK Dermatology Drug Sales and Growth Rate (2013-2018)
6.1.5 France Dermatology Drug Sales and Growth Rate (2013-2018)
6.1.6 Russia Dermatology Drug Sales and Growth Rate (2013-2018)
6.1.7 Italy Dermatology Drug Sales and Growth Rate (2013-2018)
6.2 Europe Dermatology Drug Sales and Revenue (Value) by Manufacturers (2016-2017)
6.2.1 Europe Dermatology Drug Sales by Manufacturers (2016-2017)
6.2.2 Europe Dermatology Drug Revenue by Manufacturers (2016-2017)
6.3 Europe Dermatology Drug Sales, Revenue and Market Share by Type (2013-2018)
6.3.1 Europe Dermatology Drug Sales and Sales Share by Type (2013-2018)
6.3.2 Europe Dermatology Drug Revenue and Revenue Share by Type (2013-2018)
6.4 Europe Dermatology Drug Sales, Revenue and Market Share by Application (2013-2018)
6.4.1 Europe Dermatology Drug Sales and Sales Share by Application (2013-2018)
6.4.2 Europe Dermatology Drug Revenue and Revenue Share by Application (2013-2018)
7 Asia-Pacific Dermatology Drug by Countries, Type, Application and Manufacturers
7.1 Asia-Pacific Dermatology Drug Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Dermatology Drug Sales by Countries (2013-2018)
7.1.2 Asia-Pacific Dermatology Drug Revenue by Countries (2013-2018)
7.1.3 China Dermatology Drug Sales and Growth Rate (2013-2018)
7.1.4 Japan Dermatology Drug Sales and Growth Rate (2013-2018)
7.1.5 Korea Dermatology Drug Sales and Growth Rate (2013-2018)
7.1.6 India Dermatology Drug Sales and Growth Rate (2013-2018)
7.1.7 Southeast Asia Dermatology Drug Sales and Growth Rate (2013-2018)
7.2 Asia-Pacific Dermatology Drug Sales and Revenue (Value) by Manufacturers (2016-2017)
7.2.1 Asia-Pacific Dermatology Drug Sales by Manufacturers (2016-2017)
7.2.2 Asia-Pacific Dermatology Drug Revenue by Manufacturers (2016-2017)
7.3 Asia-Pacific Dermatology Drug Sales, Revenue and Market Share by Type (2013-2018)
7.3.1 Asia-Pacific Dermatology Drug Sales and Sales Share by Type (2013-2018)
7.3.2 Asia-Pacific Dermatology Drug Revenue and Revenue Share by Type (2013-2018)
7.4 Asia-Pacific Dermatology Drug Sales, Revenue and Market Share by Application (2013-2018)
7.4.1 Asia-Pacific Dermatology Drug Sales and Sales Share by Application (2013-2018)
7.4.2 Asia-Pacific Dermatology Drug Revenue and Revenue Share by Application (2013-2018)
8 South America Dermatology Drug by Countries, Type, Application and Manufacturers
8.1 South America Dermatology Drug Sales, Revenue and Market Share by Countries
8.1.1 South America Dermatology Drug Sales by Countries (2013-2018)
8.1.2 South America Dermatology Drug Revenue by Countries (2013-2018)
8.1.3 Brazil Dermatology Drug Sales and Growth Rate (2013-2018)
8.1.4 Argentina Dermatology Drug Sales and Growth Rate (2013-2018)
8.1.5 Colombia Dermatology Drug Sales and Growth Rate (2013-2018)
8.2 South America Dermatology Drug Sales and Revenue (Value) by Manufacturers (2016-2017)
8.2.1 South America Dermatology Drug Sales by Manufacturers (2016-2017)
8.2.2 South America Dermatology Drug Revenue by Manufacturers (2016-2017)
8.3 South America Dermatology Drug Sales, Revenue and Market Share by Type (2013-2018)
8.3.1 South America Dermatology Drug Sales and Sales Share by Type (2013-2018)
8.3.2 South America Dermatology Drug Revenue and Revenue Share by Type (2013-2018)
8.4 South America Dermatology Drug Sales, Revenue and Market Share by Application (2013-2018)
8.4.1 South America Dermatology Drug Sales and Sales Share by Application (2013-2018)
8.4.2 South America Dermatology Drug Revenue and Revenue Share by Application (2013-2018)
9 Middle East and Africa Dermatology Drug by Countries, Type, Application and Manufacturers
9.1 Middle East and Africa Dermatology Drug Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Dermatology Drug Sales by Countries (2013-2018)
9.1.2 Middle East and Africa Dermatology Drug Revenue by Countries (2013-2018)
9.1.3 Saudi Arabia Dermatology Drug Sales and Growth Rate (2013-2018)
9.1.4 UAE Dermatology Drug Sales and Growth Rate (2013-2018)
9.1.5 Egypt Dermatology Drug Sales and Growth Rate (2013-2018)
9.1.6 Nigeria Dermatology Drug Sales and Growth Rate (2013-2018)
9.1.7 South Africa Dermatology Drug Sales and Growth Rate (2013-2018)
9.2 Middle East and Africa Dermatology Drug Sales and Revenue (Value) by Manufacturers (2016-2017)
9.2.1 Middle East and Africa Dermatology Drug Sales by Manufacturers (2016-2017)
9.2.2 Middle East and Africa Dermatology Drug Revenue by Manufacturers (2016-2017)
9.3 Middle East and Africa Dermatology Drug Sales, Revenue and Market Share by Type (2013-2018)
9.3.1 Middle East and Africa Dermatology Drug Sales and Sales Share by Type (2013-2018)
9.3.1 Middle East and Africa Dermatology Drug Revenue and Revenue Share by Type (2013-2018)
9.4 Middle East and Africa Dermatology Drug Sales, Revenue and Market Share by Application (2013-2018)
9.4.1 Middle East and Africa Dermatology Drug Sales and Sales Share by Application (2013-2018)
9.4.2 Middle East and Africa Dermatology Drug Revenue and Revenue Share by Application (2013-2018)
10 Global Dermatology Drug Market Segment by Type
10.1 Global Dermatology Drug Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Dermatology Drug Sales and Market Share by Type (2013-2018)
10.1.2 Global Dermatology Drug Revenue and Market Share by Type (2013-2018)
10.2 External Use Sales Growth and Price
10.2.1 Global External Use Sales Growth (2013-2018)
10.2.2 Global External Use Price (2013-2018)
10.3 Oral Sales Growth and Price
10.3.1 Global Oral Sales Growth (2013-2018)
10.3.2 Global Oral Price (2013-2018)
10.4 Injection Sales Growth and Price
10.4.1 Global Injection Sales Growth (2013-2018)
10.4.2 Global Injection Price (2013-2018)
11 Global Dermatology Drug Market Segment by Application
11.1 Global Dermatology Drug Sales Market Share by Application (2013-2018)
11.2 Psoriasis Sales Growth (2013-2018)
11.3 Skin Infections Sales Growth (2013-2018)
11.4 Acne Sales Growth (2013-2018)
11.5 Dermatitis Sales Growth (2013-2018)
11.6 Other Sales Growth (2013-2018)
12 Dermatology Drug Market Forecast (2018-2023)
12.1 Global Dermatology Drug Sales, Revenue and Growth Rate (2018-2023)
12.2 Dermatology Drug Market Forecast by Regions (2018-2023)
12.2.1 North America Dermatology Drug Market Forecast (2018-2023)
12.2.2 Europe Dermatology Drug Market Forecast (2018-2023)
12.2.3 Asia-Pacific Dermatology Drug Market Forecast (2018-2023)
12.2.4 South America Dermatology Drug Market Forecast (2018-2023)
12.2.5 Middle East and Africa Dermatology Drug Market Forecast (2018-2023)
12.3 Dermatology Drug Market Forecast by Type (2018-2023)
12.3.1 Global Dermatology Drug Sales Forecast by Type (2018-2023)
12.3.2 Global Dermatology Drug Market Share Forecast by Type (2018-2023)
12.4 Dermatology Drug Market Forecast by Application (2018-2023)
12.4.1 Global Dermatology Drug Sales Forecast by Application (2018-2023)
12.4.2 Global Dermatology Drug Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source


List of Tables and Figures

Figure Dermatology Drug Picture
Table Product Specifications of Dermatology Drug
Figure Global Dermatology Drug CAGR (%), Y-o-Y Growth (&) and Market Size, 2013-2023 (USD Million)
Figure Global Dermatology Drug CAGR (%), Y-o-Y Growth (&) and Market Size, 2013-2023 (Sales)
Figure Global Sales Market Share of Dermatology Drug by Types in 2017
Figure External Use Picture
Table Major Manufacturers of External Use
Figure Oral Picture
Table Major Manufacturers of Oral
Figure Injection Picture
Table Major Manufacturers of Injection
Figure Dermatology Drug Sales Market Share by Applications in 2017
Figure Psoriasis Picture
Figure Skin Infections Picture
Figure Acne Picture
Figure Dermatitis Picture
Figure Other Picture
Figure United States Dermatology Drug Revenue (Value) and Growth Rate (2013-2023)
Figure Canada Dermatology Drug Revenue (Value) and Growth Rate (2013-2023)
Figure Mexico Dermatology Drug Revenue (Value) and Growth Rate (2013-2023)
Figure Germany Dermatology Drug Revenue (Value) and Growth Rate (2013-2023)
Figure France Dermatology Drug Revenue (Value) and Growth Rate (2013-2023)
Figure UK Dermatology Drug Revenue (Value) and Growth Rate (2013-2023)
Figure Russia Dermatology Drug Revenue (Value) and Growth Rate (2013-2023)
Figure Italy Dermatology Drug Revenue (Value) and Growth Rate (2013-2023)
Figure China Dermatology Drug Revenue (Value) and Growth Rate (2013-2023)
Figure Japan Dermatology Drug Revenue (Value) and Growth Rate (2013-2023)
Figure Korea Dermatology Drug Revenue (Value) and Growth Rate (2013-2023)
Figure India Dermatology Drug Revenue (Value) and Growth Rate (2013-2023)
Figure Southeast Asia Dermatology Drug Revenue (Value) and Growth Rate (2013-2023)
Figure Brazil Dermatology Drug Revenue (Value) and Growth Rate (2013-2023)
Figure Egypt Dermatology Drug Revenue (Value) and Growth Rate (2013-2023)
Figure Saudi Arabia Dermatology Drug Revenue (Value) and Growth Rate (2013-2023)
Figure South Africa Dermatology Drug Revenue (Value) and Growth Rate (2013-2023)
Figure Nigeria Dermatology Drug Revenue (Value) and Growth Rate (2013-2023)
Table AbbVie Headquarter, Established, Main Business and Finance Overview (2017)
Table AbbVie Dermatology Drug Production Bases, Sales Regions and Major Competitors
Table AbbVie Dermatology Drug Product
Table AbbVie Dermatology Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global AbbVie Dermatology Drug Sales Market Share in 2017
Figure Global AbbVie Dermatology Drug Revenue Market Share in 2017
Table Johnson & Johnson Headquarter, Established, Main Business and Finance Overview (2017)
Table Johnson & Johnson Dermatology Drug Production Bases, Sales Regions and Major Competitors
Table Johnson & Johnson Dermatology Drug Product
Table Johnson & Johnson Dermatology Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Johnson & Johnson Dermatology Drug Sales Market Share in 2017
Figure Global Johnson & Johnson Dermatology Drug Revenue Market Share in 2017
Table Bayer Headquarter, Established, Main Business and Finance Overview (2017)
Table Bayer Dermatology Drug Production Bases, Sales Regions and Major Competitors
Table Bayer Dermatology Drug Product
Table Bayer Dermatology Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Bayer Dermatology Drug Sales Market Share in 2017
Figure Global Bayer Dermatology Drug Revenue Market Share in 2017
Table Galderma Headquarter, Established, Main Business and Finance Overview (2017)
Table Galderma Dermatology Drug Production Bases, Sales Regions and Major Competitors
Table Galderma Dermatology Drug Product
Table Galderma Dermatology Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Galderma Dermatology Drug Sales Market Share in 2017
Figure Global Galderma Dermatology Drug Revenue Market Share in 2017
Table Bristol-Myers Squibb Headquarter, Established, Main Business and Finance Overview (2017)
Table Bristol-Myers Squibb Dermatology Drug Production Bases, Sales Regions and Major Competitors
Table Bristol-Myers Squibb Dermatology Drug Product
Table Bristol-Myers Squibb Dermatology Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Bristol-Myers Squibb Dermatology Drug Sales Market Share in 2017
Figure Global Bristol-Myers Squibb Dermatology Drug Revenue Market Share in 2017
Table Novartis Headquarter, Established, Main Business and Finance Overview (2017)
Table Novartis Dermatology Drug Production Bases, Sales Regions and Major Competitors
Table Novartis Dermatology Drug Product
Table Novartis Dermatology Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Novartis Dermatology Drug Sales Market Share in 2017
Figure Global Novartis Dermatology Drug Revenue Market Share in 2017
Table Pfizer Headquarter, Established, Main Business and Finance Overview (2017)
Table Pfizer Dermatology Drug Production Bases, Sales Regions and Major Competitors
Table Pfizer Dermatology Drug Product
Table Pfizer Dermatology Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Pfizer Dermatology Drug Sales Market Share in 2017
Figure Global Pfizer Dermatology Drug Revenue Market Share in 2017
Table Merz Pharma Headquarter, Established, Main Business and Finance Overview (2017)
Table Merz Pharma Dermatology Drug Production Bases, Sales Regions and Major Competitors
Table Merz Pharma Dermatology Drug Product
Table Merz Pharma Dermatology Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Merz Pharma Dermatology Drug Sales Market Share in 2017
Figure Global Merz Pharma Dermatology Drug Revenue Market Share in 2017
Table Valeant Headquarter, Established, Main Business and Finance Overview (2017)
Table Valeant Dermatology Drug Production Bases, Sales Regions and Major Competitors
Table Valeant Dermatology Drug Product
Table Valeant Dermatology Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Valeant Dermatology Drug Sales Market Share in 2017
Figure Global Valeant Dermatology Drug Revenue Market Share in 2017
Table LEO Pharma Headquarter, Established, Main Business and Finance Overview (2017)
Table LEO Pharma Dermatology Drug Production Bases, Sales Regions and Major Competitors
Table LEO Pharma Dermatology Drug Product
Table LEO Pharma Dermatology Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global LEO Pharma Dermatology Drug Sales Market Share in 2017
Figure Global LEO Pharma Dermatology Drug Revenue Market Share in 2017
Table GlaxoSmithKline
Table GlaxoSmithKline Dermatology Drug
Table Global Dermatology Drug Sales by Manufacturer (2016-2017)
Figure Global Dermatology Drug Sales Market Share by Manufacturer in 2016
Figure Global Dermatology Drug Sales Market Share by Manufacturer in 2017
Table Global Dermatology Drug Revenue by Manufacturer (2016-2017)
Figure Global Dermatology Drug Revenue Market Share by Manufacturer in 2016
Figure Global Dermatology Drug Revenue Market Share by Manufacturer in 2017
Table Global Dermatology Drug Price by Manufacturer (2016-2017)
Figure Top 3 Dermatology Drug Manufacturer (Revenue) Market Share in 2017
Figure Top 6 Dermatology Drug Manufacturer (Revenue) Market Share in 2017
Figure Global Dermatology Drug Sales and Growth Rate (2013-2018)
Figure Global Dermatology Drug Revenue and Growth Rate (2013-2018)
Table Global Dermatology Drug Sales by Regions (2013-2018)
Table Global Dermatology Drug Sales Market Share by Regions (2013-2018)
Table Global Dermatology Drug Revenue by Regions (2013-2018)
Figure Global Dermatology Drug Revenue Market Share by Regions in 2013
Figure Global Dermatology Drug Revenue Market Share by Regions in 2017
Figure North America Dermatology Drug Sales and Growth Rate (2013-2018)
Figure North America Dermatology Drug Revenue and Growth Rate (2013-2018)
Figure Europe Dermatology Drug Sales and Growth Rate (2013-2018)
Figure Europe Dermatology Drug Revenue and Growth Rate (2013-2018)
Figure Asia-Pacific Dermatology Drug Sales and Growth Rate (2013-2018)
Figure Asia-Pacific Dermatology Drug Revenue and Growth Rate (2013-2018)
Figure South America Dermatology Drug Sales and Growth Rate (2013-2018)
Figure South America Dermatology Drug Revenue and Growth Rate (2013-2018)
Figure Middle East and Africa Dermatology Drug Sales and Growth Rate (2013-2018)
Figure Middle East and Africa Dermatology Drug Revenue and Growth Rate (2013-2018)
Figure North America Dermatology Drug Revenue and Growth Rate (2013-2018)
Table North America Dermatology Drug Sales by Countries (2013-2018)
Table North America Dermatology Drug Sales Market Share by Countries (2013-2018)
Figure North America Dermatology Drug Sales Market Share by Countries in 2013
Figure North America Dermatology Drug Sales Market Share by Countries in 2017
Table North America Dermatology Drug Revenue by Countries (2013-2018)
Table North America Dermatology Drug Revenue Market Share by Countries (2013-2018)
Figure North America Dermatology Drug Revenue Market Share by Countries in 2013
Figure North America Dermatology Drug Revenue Market Share by Countries in 2017
Figure United States Dermatology Drug Sales and Growth Rate (2013-2018)
Figure Canada Dermatology Drug Sales and Growth Rate (2013-2018)
Figure Mexico Dermatology Drug Sales and Growth Rate (2013-2018)
Table North America Dermatology Drug Sales by Manufacturer (2016-2017)
Figure North America Dermatology Drug Sales Market Share by Manufacturer in 2016
Figure North America Dermatology Drug Sales Market Share by Manufacturer in 2017
Table North America Dermatology Drug Revenue by Manufacturer (2016-2017)
Figure North America Dermatology Drug Revenue Market Share by Manufacturer in 2016
Figure North America Dermatology Drug Revenue Market Share by Manufacturer in 2017
Table North America Dermatology Drug Sales by Type (2013-2018)
Table North America Dermatology Drug Sales Share by Type (2013-2018)
Table North America Dermatology Drug Revenue by Type (2013-2018)
Table North America Dermatology Drug Revenue Share by Type (2013-2018)
Table North America Dermatology Drug Sales by Application (2013-2018)
Table North America Dermatology Drug Sales Share by Application (2013-2018)
Table North America Dermatology Drug Revenue by Application (2013-2018)
Table North America Dermatology Drug Revenue Share by Application (2013-2018)
Figure Europe Dermatology Drug Revenue and Growth Rate (2013-2018)
Table Europe Dermatology Drug Sales by Countries (2013-2018)
Table Europe Dermatology Drug Sales Market Share by Countries (2013-2018)
Table Europe Dermatology Drug Revenue by Countries (2013-2018)
Figure Europe Dermatology Drug Revenue Market Share by Countries in 2016
Figure Europe Dermatology Drug Revenue Market Share by Countries in 2017
Figure Germany Dermatology Drug Sales and Growth Rate (2013-2018)
Figure UK Dermatology Drug Sales and Growth Rate (2013-2018)
Figure France Dermatology Drug Sales and Growth Rate (2013-2018)
Figure Russia Dermatology Drug Sales and Growth Rate (2013-2018)
Figure Italy Dermatology Drug Sales and Growth Rate (2013-2018)
Table Europe Dermatology Drug Sales by Manufacturer (2016-2017)
Figure Europe Dermatology Drug Sales Market Share by Manufacturer in 2016
Figure Europe Dermatology Drug Sales Market Share by Manufacturer in 2017
Table Europe Dermatology Drug Revenue by Manufacturer (2016-2017)
Figure Europe Dermatology Drug Revenue Market Share by Manufacturer in 2016
Figure Europe Dermatology Drug Revenue Market Share by Manufacturer in 2017
Table Europe Dermatology Drug Sales by Type (2013-2018)
Table Europe Dermatology Drug Sales Share by Type (2013-2018)
Table Europe Dermatology Drug Revenue by Type (2013-2018)
Table Europe Dermatology Drug Revenue Share by Type (2013-2018)
Table Europe Dermatology Drug Sales by Application (2013-2018)
Table Europe Dermatology Drug Sales Share by Application (2013-2018)
Table Europe Dermatology Drug Revenue by Application (2013-2018)
Table Europe Dermatology Drug Revenue Share by Application (2013-2018)
Figure Asia-Pacific Dermatology Drug Revenue and Growth Rate (2013-2018)
Table Asia-Pacific Dermatology Drug Sales by Countries (2013-2018)
Table Asia-Pacific Dermatology Drug Sales Market Share by Countries (2013-2018)
Figure Asia-Pacific Dermatology Drug Sales Market Share by Countries 2017
Table Asia-Pacific Dermatology Drug Revenue by Countries (2013-2018)
Figure Asia-Pacific Dermatology Drug Revenue Market Share by Countries 2017
Figure China Dermatology Drug Sales and Growth Rate (2013-2018)
Figure Japan Dermatology Drug Sales and Growth Rate (2013-2018)
Figure Korea Dermatology Drug Sales and Growth Rate (2013-2018)
Figure India Dermatology Drug Sales and Growth Rate (2013-2018)
Figure Southeast Asia Dermatology Drug Sales and Growth Rate (2013-2018)
Table Asia-Pacific Dermatology Drug Sales by Manufacturer (2016-2017)
Figure Asia-Pacific Dermatology Drug Sales Market Share by Manufacturer in 2016
Figure Asia-Pacific Dermatology Drug Sales Market Share by Manufacturer in 2017
Table Asia-Pacific Dermatology Drug Revenue by Manufacturer (2016-2017)
Figure Asia-Pacific Dermatology Drug Revenue Market Share by Manufacturer in 2016
Figure Asia-Pacific Dermatology Drug Revenue Market Share by Manufacturer in 2017
Table Asia-Pacific Dermatology Drug Sales by Type (2013-2018)
Table Asia-Pacific Dermatology Drug Sales Share by Type (2013-2018)
Table Asia-Pacific Dermatology Drug Revenue by Type (2013-2018)
Table Asia-Pacific Dermatology Drug Revenue Share by Type (2013-2018)
Table Asia-Pacific Dermatology Drug Sales by Application (2013-2018)
Table Asia-Pacific Dermatology Drug Sales Share by Application (2013-2018)
Table Asia-Pacific Dermatology Drug Revenue by Application (2013-2018)
Table Asia-Pacific Dermatology Drug Revenue Share by Application (2013-2018)
Figure South America Dermatology Drug Revenue and Growth Rate (2013-2018)
Table South America Dermatology Drug Sales by Countries (2013-2018)
Table South America Dermatology Drug Sales Market Share by Countries (2013-2018)
Figure South America Dermatology Drug Sales Market Share by Countries in 2017
Table South America Dermatology Drug Revenue by Countries (2013-2018)
Table South America Dermatology Drug Revenue Market Share by Countries (2013-2018)
Figure South America Dermatology Drug Revenue Market Share by Countries in 2017
Figure Brazil Dermatology Drug Sales and Growth Rate (2013-2018)
Figure Argentina Dermatology Drug Sales and Growth Rate (2013-2018)
Figure Colombia Dermatology Drug Sales and Growth Rate (2013-2018)
Table South America D
  • 2018-2023 Global Botox Consumption Market Report
    Published: 20-Sep-2018        Price: US 4660 Onwards        Pages: 138
    In this report, LP Information covers the present scenario (with the base year being 2017) and the growth prospects of global Botox market for 2018-2023. Botox is a neurotoxic protein produced by the bacterium Clostridium botulinum and related species in the reproduction process. Botox is a polypeptide which molecular weight is 150kD and is also one of the most poisonous natural proteins. It is so easy to be produced, purified and refined due to its stable property that Botox is u......
  • Global Acne Drugs Market Insights, Forecast to 2025
    Published: 12-Sep-2018        Price: US 3900 Onwards        Pages: 111
    This report studies the global market size of Acne Drugs in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Acne Drugs in these regions. This research report categorizes the global Acne Drugs market by players/brands, region, type and application. This report also studies the global market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenge......
  • 2018-2023 Global Acne Medication Consumption Market Report
    Published: 10-Sep-2018        Price: US 4660 Onwards        Pages: 134
    In this report, LP Information covers the present scenario (with the base year being 2017) and the growth prospects of global Acne Medication market for 2018-2023. Acne medications are drugs that are indicated for the treatment of acne. Over the next five years, LPI(LP Information) projects that Acne Medication will register a xx% CAGR in terms of revenue, reach US$ xx million by 2023, from US$ xx million in 2017. This report presents a comprehensive overvie......
  • Global Acne Partnering 2012 to 2018
    Published: 01-Sep-2018        Price: US 1995 Onwards        Pages: 100
    "Delivery of this report will take 1-3 days after purchase." The Global Acne Partnering Terms and Agreements since 2012 report provides understanding and access to partnering deals and agreements entered into by the world's leading healthcare companies. - Trends in partnering deals - Top deals by value - Deals listed by company A-Z, industry sector, stage of development, technology type The report provides understanding and acce......
  • Global Cosmetics Partnering 2012 to 2018
    Published: 01-Sep-2018        Price: US 1995 Onwards        Pages: 100
    "Delivery of this report will take 1-3 days after purchase." The Global Cosmetics Partnering Terms and Agreements since 2012 report provides understanding and access to partnering deals and agreements entered into by the world's leading healthcare companies. - Trends in partnering deals - Top deals by value - Deals listed by company A-Z, industry sector, stage of development, technology type The report provides understanding and......
  • Global Dermatitis Partnering 2012 to 2018
    Published: 01-Sep-2018        Price: US 1995 Onwards        Pages: 100
    "Delivery of this report will take 1-3 days after purchase." The Global Dermatitis Partnering Terms and Agreements since 2012 report provides understanding and access to partnering deals and agreements entered into by the world's leading healthcare companies. - Trends in partnering deals - Top deals by value - Deals listed by company A-Z, industry sector, stage of development, technology type The report provides understanding an......
  • Global Psoriasis Partnering 2012 to 2018
    Published: 01-Sep-2018        Price: US 1995 Onwards        Pages: 100
    "Delivery of this report will take 1-3 days after purchase." The Global Psoriasis Partnering Terms and Agreements since 2012 report provides understanding and access to partnering deals and agreements entered into by the world's leading healthcare companies. - Trends in partnering deals - Top deals by value - Deals listed by company A-Z, industry sector, stage of development, technology type The report provides understanding and......
  • Global Wound Healing Partnering 2012 to 2018
    Published: 01-Sep-2018        Price: US 1995 Onwards        Pages: 250
    "Delivery of this report will take 1-3 days after purchase." The Global Wound Healing Partnering Terms and Agreements since 2012 report provides understanding and access to partnering deals and agreements entered into by the world's leading healthcare companies. - Trends in partnering deals - Top deals by value - Deals listed by company A-Z, industry sector, stage of development, technology type The report provides understanding......
  • Global Systemic Lupus Erythematosus Partnering 2012 to 2018
    Published: 01-Sep-2018        Price: US 1995 Onwards        Pages: 100
    "Delivery of this report will take 1-3 days after purchase." The Global Systemic Lupus Erythematosus Partnering Terms and Agreements since 2012 report provides understanding and access to partnering deals and agreements entered into by the world's leading healthcare companies. - Trends in partnering deals - Top deals by value - Deals listed by company A-Z, industry sector, stage of development, technology type The report provide......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs